Stella Sarraf active positions
| Companies | Position | Start | End |
|---|---|---|---|
Spinogenix, Inc.
 Spinogenix, Inc. Pharmaceuticals: MajorHealth Technology Spinogenix, Inc. provides biotechnology services. It offers therapeutics, neurodegeneration, amyloids, traumatic brain injury and neurorestorative. The company was founded by Stella Sarraf in 2016 and is headquartered in San Diego, CA. | Director/Board Member | 31/12/2015 | - |
| Chief Executive Officer | 31/12/2015 | - | |
| Founder | 31/12/2015 | - | |
| President | 31/12/2015 | - | |
Amydis, Inc.
 Amydis, Inc. Miscellaneous Commercial ServicesCommercial Services This technology allows physicians and researchers to explore the eye for a broad spectrum of diseases, which have previously required long-term clinical evaluation and invasive testing for definitive diagnosis. Amydis has a discovery platform and proprietary know-how that positions it as a first mover and leader in developing ocular tracers for human diseases. The American company was founded in 2013 by Stella Sarraf, who has been the CEO since then. | Director/Board Member | 31/12/2012 | - |
| Chief Executive Officer | 31/12/2012 | - | |
| Founder | 31/12/2012 | - |
Career history of Stella Sarraf
Statistics
International
| United States | 3 |
Operational
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
| Founder | 2 |
Sectoral
| Health Technology | 2 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Spinogenix, Inc.
Spinogenix, Inc. Pharmaceuticals: MajorHealth Technology Spinogenix, Inc. provides biotechnology services. It offers therapeutics, neurodegeneration, amyloids, traumatic brain injury and neurorestorative. The company was founded by Stella Sarraf in 2016 and is headquartered in San Diego, CA. | Health Technology |
Amydis, Inc.
Amydis, Inc. Miscellaneous Commercial ServicesCommercial Services This technology allows physicians and researchers to explore the eye for a broad spectrum of diseases, which have previously required long-term clinical evaluation and invasive testing for definitive diagnosis. Amydis has a discovery platform and proprietary know-how that positions it as a first mover and leader in developing ocular tracers for human diseases. The American company was founded in 2013 by Stella Sarraf, who has been the CEO since then. | Commercial Services |
- Stock Market
- Insiders
- Stella Sarraf
- Experience
